IL326704A - פורמולציות נוגדן נגד קולטן אינסולין בריכוז גבוה ושימושים שלהן - Google Patents

פורמולציות נוגדן נגד קולטן אינסולין בריכוז גבוה ושימושים שלהן

Info

Publication number
IL326704A
IL326704A IL326704A IL32670426A IL326704A IL 326704 A IL326704 A IL 326704A IL 326704 A IL326704 A IL 326704A IL 32670426 A IL32670426 A IL 32670426A IL 326704 A IL326704 A IL 326704A
Authority
IL
Israel
Prior art keywords
high concentration
insulin receptor
receptor antibody
concentration formulations
formulations
Prior art date
Application number
IL326704A
Other languages
English (en)
Inventor
Alona Teran
Lucy Pan
Laura Pack
Michael Covarrubias
Michael Burke
Tayeb Bouamama
Original Assignee
Rezolute Inc
Alona Teran
Lucy Pan
Laura Pack
Michael Covarrubias
Michael Burke
Tayeb Bouamama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rezolute Inc, Alona Teran, Lucy Pan, Laura Pack, Michael Covarrubias, Michael Burke, Tayeb Bouamama filed Critical Rezolute Inc
Publication of IL326704A publication Critical patent/IL326704A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39591—Stabilisation, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL326704A 2023-08-24 2024-08-23 פורמולציות נוגדן נגד קולטן אינסולין בריכוז גבוה ושימושים שלהן IL326704A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363578557P 2023-08-24 2023-08-24
PCT/US2024/043521 WO2025043134A1 (en) 2023-08-24 2024-08-23 High concentration formulations for anti-insulin receptor antibody and uses thereof

Publications (1)

Publication Number Publication Date
IL326704A true IL326704A (he) 2026-04-01

Family

ID=92746295

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326704A IL326704A (he) 2023-08-24 2024-08-23 פורמולציות נוגדן נגד קולטן אינסולין בריכוז גבוה ושימושים שלהן

Country Status (5)

Country Link
AR (1) AR133637A1 (he)
AU (1) AU2024326775A1 (he)
IL (1) IL326704A (he)
TW (1) TW202508633A (he)
WO (1) WO2025043134A1 (he)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
WO2009048462A1 (en) 2007-10-09 2009-04-16 Dexcom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8359965B2 (en) 2007-09-17 2013-01-29 Oxford J Craig Apparatus and method for broad spectrum radiation attenuation
US8926976B2 (en) 2009-09-25 2015-01-06 Xoma Technology Ltd. Modulators
US9100245B1 (en) 2012-02-08 2015-08-04 Amazon Technologies, Inc. Identifying protected media files
US9306926B2 (en) 2013-03-15 2016-04-05 Brian A. Truong User authentication using unique hidden identifiers
CA2994841A1 (en) 2015-08-06 2017-02-09 Xoma (Us) Llc Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
IL283229B2 (he) * 2018-11-21 2025-08-01 Regeneron Pharma פורמולציה של חלבון בריכוז גבוה
US20260070996A1 (en) * 2022-05-20 2026-03-12 Rezolute, Inc. Formulations for anti-insulin receptor antibody and uses thereof

Also Published As

Publication number Publication date
AU2024326775A1 (en) 2026-04-09
TW202508633A (zh) 2025-03-01
WO2025043134A1 (en) 2025-02-27
AR133637A1 (es) 2025-10-15

Similar Documents

Publication Publication Date Title
CY1123909T1 (el) Σταθεροποιημενα σκευασματα που περιεχουν αντισωματα κατα του υποδοχεα της ιντερλευκινης-6 (il-6r)
IL285182A (he) נוגדנים וקולטנים לאנטיגן כימריים ספציפיים לקולטן יתום מטיפוס 1 דמוי קולטן לטירוזין קינאז (ror1)
IL307879A (he) פורמולציות נוגדנים ביספציפיים בריכוז גבוה
MX2021007368A (es) Anticuerpos anti-receptor de transferrina y usos de los mismos.
CL2008002886A1 (es) Region constante de un anticuerpo humano; anticuerpo anti-receptor de interleucina-6 (il-6) y composicion farmaceutica que la comprende.
IL317063A (he) פורמולציות לנוגדן נגד קולטן אינסולין ושימושים שלהן
IL295381B1 (he) תרכובות של קולטן אנטיגן כימרי של תאי t מוכוון ל- bcma ושיטות ושימושים שלהם
GB2606869B (en) CLL1-Targeting chimeric antigen receptor and application thereof
NZ591943A (en) Anti-tgf-beta receptor ii antibodies
IL295384B1 (he) תכשירים של תאי t עם קולטן לאנטיגן כימרי מוכוון נגד cd19 ושיטות ושימושים שלהם
IL311175A (he) נוגדנים אנטי-קולטן טרנספרין ושימושים בהם
MX2021005085A (es) Formulacion de anticuerpo.
IL315438A (he) נוגדנים אנטי-cd3 חדשים ושימושים בהם
IL326704A (he) פורמולציות נוגדן נגד קולטן אינסולין בריכוז גבוה ושימושים שלהן
IL325570A (he) נוגדן כנגד cd3 ושימוש בו
CA3302827A1 (en) High concentration formulations for anti-insulin receptor antibody and uses thereof
IL310432A (he) נוגדנים ומצומדי נוגדן ספציפיים לנקטין-4 ושיטות לשימוש בהם
IL284208A (he) פורמולציות נוגדנים הקושרים cd137 אנושי ושימושים שלהן
CR20230122A (es) Formulaciones de anticuerpos terapéuticos
IL310275A (he) פורמולציות נוגדן
IL299152A (he) פורמולציות מיוצבות הכוללות נוגדנים נגד ctla-4
IL320555A (he) תכשירי רוקחות המכילים נוגדנים לקולטני tslp אנטי-אנושיים ושיטות לשימוש בהם
IL318326A (he) פורמולציות ושיטות נוגדני אנטי-קיט
HK40106376A (en) High concentration antibody formulations
TW202617183A (zh) 治療性抗體調配物